Sisaf Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Sisaf Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11217
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥101,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Sisaf Ltd (Sisaf) is a drug delivery company which designs and develops topical delivery systems for cosmetic, medical, and skin care applications. The company manufactures and markets products and drug delivery solutions using ProSilic, a nano-silicon technology platform. It offers ProSillic-RX, for gene therapy or oral delivery of large unstable peptides and proteins; ProSillic-OTC products, for cosmeceuticals or nutraceuticals. Sisaf’s platform technology uses elemental silicon particle to allow active compounds to penetrate into the deeper layers of the skin and finds application in the treatment of diseases such as skin melanoma, acne, psoriasis, scar, wound healing, cancer, diabetes, and Alzheimers disease, among others. The company provides formulation services; and licenses its technologies to clients in the life science industry. Its products are used in pharmaceutical, cosmetics, biotech, and lab technology sectors. Sisaf is headquartered in Belfast, the UK.

Sisaf Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Sisaf Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sisaf Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Sisaf Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sisaf Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Sisaf Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Sisaf Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Sisaf Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Sisaf Raises USD4.3 Million in Venture Financing 11
SiSaf Raises USD3.5 Million in Series A Financing 12
SiSaf Raises USD0.6 Million in Venture Financing 13
SiSaf Raises USD0.8 Million in Venture Financing 14
Private Equity 15
SiSaf Plans to Raise Funds in Financing Round 15
Partnerships 16
Croda International and SiSaf Enter into Agreement 16
Acquisition 17
Croda International Acquires Minority Stake in SiSaf 17
Sisaf Ltd – Key Competitors 18
Sisaf Ltd – Key Employees 19
Sisaf Ltd – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Sisaf Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Sisaf Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sisaf Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Sisaf Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sisaf Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Sisaf Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Sisaf Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Sisaf Raises USD4.3 Million in Venture Financing 11
SiSaf Raises USD3.5 Million in Series A Financing 12
SiSaf Raises USD0.6 Million in Venture Financing 13
SiSaf Raises USD0.8 Million in Venture Financing 14
SiSaf Plans to Raise Funds in Financing Round 15
Croda International and SiSaf Enter into Agreement 16
Croda International Acquires Minority Stake in SiSaf 17
Sisaf Ltd, Key Competitors 18
Sisaf Ltd, Key Employees 19
Sisaf Ltd, Other Locations 20
Sisaf Ltd, Subsidiaries 20

List of Figures
Sisaf Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Sisaf Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Sisaf Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Sisaf Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Sisaf Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sisaf Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Sisaf Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sisaf Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Sisaf Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Sisaf Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Tecumseh Products Company:企業の戦略的SWOT分析
    Tecumseh Products Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • GelTech Solutions Inc (GLTC):企業の財務・戦略的SWOT分析
    Summary GelTech Solutions Inc (GelTech Solutions) is a chemical solutions company that manufactures and markets environmentally-friendly chemicals and fire prevention and suppression products. It offers products such as fireice shield and soil2O. Its fireice shield is a fire suppression product that …
  • Aalborg Portland Holding A/S:企業の戦略・SWOT・財務情報
    Aalborg Portland Holding A/S - Strategy, SWOT and Corporate Finance Report Summary Aalborg Portland Holding A/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Medical Prognosis Institute AS (MPI):医療機器:M&Aディール及び事業提携情報
    Summary Medical Prognosis Institute A/S (MPI) is a precision medicine provider that offers cancer treatment solutions. The company offers drug response prediction platforms that provide tools for rationalized drug development and personalized medicine. It offers lead compound selection, drug rescue …
  • Intrexon Corp (XON)-製薬・医療分野:企業M&A・提携分析
    Summary Intrexon Corp (Intrexon), formerly Genomatix Corp is a provider of therapeutic solutions. The company operates through its divisions such as human therapeutics, protein production, industrial products, agricultural biotech, and animal sciences. Its human therapeutics division develops therap …
  • Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329):製薬・医療:M&Aディール及び事業提携情報
    Summary Tianjin Zhongxin Pharmaceutical Group Corp Ltd (TZPG) is engaged in the manufacturing of traditional Chinese medicine, western medicine and health products. The company offers Chinese patent medicines, Chinese medicinal materials, chemical medicines, dietary supplements, pharmaceutical raw m …
  • GW Pharmaceuticals Plc (GWPH):企業の財務・戦略的SWOT分析
    GW Pharmaceuticals Plc (GWPH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • NovoCure Ltd (NVCR):製薬・医療:M&Aディール及び事業提携情報
    Summary NovoCure Ltd (NovoCure) is an drug company that offers development and commercialization of novel therapies for tumor treating fields. The company’s pipeline products find application in cancer indications such as malignant melanoma, hepatocellular carcinoma, ovarian cancer, breast cancer an …
  • Stagecoach Group plc:企業の戦略・SWOT・財務情報
    Stagecoach Group plc - Strategy, SWOT and Corporate Finance Report Summary Stagecoach Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Accelerate Diagnostics Inc (AXDX):医療機器:M&Aディール及び事業提携情報
    Summary Accelerate Diagnostics Inc (Accelerate) is an in vitro diagnostics company that undertakes the development and commercialization of instrumentation for identification and testing the antibiotic susceptibility of infectious pathogens. Its product portfolio includes Accelerate Pheno system, in …
  • Nestle (Malaysia) Bhd:戦略・SWOT・企業財務分析
    Nestle (Malaysia) Bhd - Strategy, SWOT and Corporate Finance Report Summary Nestle (Malaysia) Bhd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Cleco Corporate Holdings, LLC:企業の戦略・SWOT・財務情報
    Cleco Corporate Holdings, LLC - Strategy, SWOT and Corporate Finance Report Summary Cleco Corporate Holdings, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Kallpa Generacion SA:発電所・企業SWOT分析
    Kallpa Generacion SA - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employee …
  • Bangladesh Power Development Board:企業の戦略的SWOT分析
    Bangladesh Power Development Board - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Mitsui Chemicals Inc (4183):企業の財務・戦略的SWOT分析
    Mitsui Chemicals Inc (4183) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Galen Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Galen Ltd (Galen), a subsidiary of Almac Group Ltd is a marketer of pharmaceutical products. The company’s products include trustsaver, calceos, salivix, daunoxome, flotros, histofreezer, laxido, and saline steripoules, among others. It offers products in various therapy areas including angi …
  • Beacon Industries Inc.:企業の戦略・SWOT・財務分析
    Beacon Industries Inc. - Strategy, SWOT and Corporate Finance Report Summary Beacon Industries Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • The AES Corporation:企業の戦略・SWOT・財務分析
    The AES Corporation - Strategy, SWOT and Corporate Finance Report Summary The AES Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • GenKyoTex SA (GKTX):製薬・医療:M&Aディール及び事業提携情報
    Summary GenKyoTex SA (GenKyoTex), formerly Genticel SA, is a biopharmaceutical company that develops NOX therapies. The company develops targeted NOX inhibitors and molecule therapeutics that inhibit the NOX family of enzymes. GenKyoTex’s lead product candidate, GKT831, a selective NOX1/4 inhibitor, …
  • PharmaEssentia Corp (6446)-製薬・医療分野:企業M&A・提携分析
    Summary PharmaEssentia Corp (PharmaEssentia) is a research and development company that develops therapeutic products for the treatment of human diseases. The company’s pipeline product include P1101, a new generation PEG-Interferon-alpha-2b which is developed using PEGylation technology platform. I …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆